Behavioral: B-HIPE (Brief High Impact Preparatory Experience) ( DrugBank: - )
1 disease
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
13 | Multiple sclerosis/Neuromyelitis optica | 1 |
13. Multiple sclerosis/Neuromyelitis optica
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04881422 (ClinicalTrials.gov) | July 15, 2018 | 28/4/2021 | Sport, Rehabilitation and Nutrition in Multiple Sclerosis: The LINUS Project | Sport, Rehabilitation and Nutrition in Multiple Sclerosis: An Innovative Multidisciplinary High Impact Intervention for the Lifestyle Change | Multiple Sclerosis | Behavioral: B-HIPE (Brief High Impact Preparatory Experience) | Fondazione Don Carlo Gnocchi Onlus | NULL | Recruiting | 18 Years | 70 Years | All | 30 | N/A | Italy |